MLchartDataset catalogue

acyclic nucleoside phosphonate prodrug ABI-1968

Term · Oncology and biomedicine · MLC-T-ONC-009636

A prodrug of an acyclic nucleoside phosphonate, with potential anti-viral and antineoplastic activities. Upon administration, acyclic nucleoside phosphonate prodrug ABI-1968 is taken up by viral-infected cells and converted to its active metabolite. The metabolite is incorporated into DNA chains by DNA polymerases, which results in the termination of DNA synthesis, inhibits viral replication and induces apoptosis and inhibits the proliferation of susceptible virally-infected tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-009636
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009636",
  "term": "acyclic nucleoside phosphonate prodrug ABI-1968",
  "field": "Oncology and biomedicine",
  "definition": "A prodrug of an acyclic nucleoside phosphonate, with potential anti-viral and antineoplastic activities. Upon administration, acyclic nucleoside phosphonate prodrug ABI-1968 is taken up by viral-infected cells and converted to its active metabolite. The metabolite is incorporated into DNA chains by DNA polymerases, which results in the termination of DNA synthesis, inhibits viral replication and induces apoptosis and inhibits the proliferation of susceptible virally-infected tumor cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/acyclic-nucleoside-phosphonate-prodrug-abi-1968/"
}

Record 348 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.